0001209191-16-150139.txt : 20161115 0001209191-16-150139.hdr.sgml : 20161115 20161115160521 ACCESSION NUMBER: 0001209191-16-150139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161114 FILED AS OF DATE: 20161115 DATE AS OF CHANGE: 20161115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frenkel Ran CENTRAL INDEX KEY: 0001623108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 161999724 MAIL ADDRESS: STREET 1: KARYOPHARM THERAPEUTICS, INC. STREET 2: 85 WELLS AVENUE, 2ND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-14 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001623108 Frenkel Ran C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 0 1 0 0 Chief Dev Operations Officer Common Stock 2016-11-14 4 S 0 3309 10.0593 D 14691 D This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.13, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Christopher B. Primiano as attorney-in-fact for Ran Frenkel 2016-11-15